British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
about
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsEfavirenz versus nevirapine as a non-nucleoside reverse transcriptase inhibitor in initial combination antiretroviral therapy for HIV infectionEfavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsAssessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users.Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversionPENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS.Atazanavir: a novel HIV-1 protease inhibitor.Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy.HIV resistance testing in the USA--a model for the application of pharmacogenomics in the clinical setting.Audit of the management of antiretroviral treatment-naïve HIV patients in Greater Manchester, UK.Efficacy of generic highly active antiretroviral therapy in HIV-1 infected individuals in Nigeria.No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors.Initial antiretroviral regimens.Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.Sequencing to NRTI plus NNRTI-only combinations after virological failure of protease inhibitor-based combination HIV-1 therapy.The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): a six-month prospective, follow-up study.Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission.Trends in the use of highly active antiretroviral therapy in western Denmark 1996-2000.Efficacy, Safety and Pharmacokinetics of Once-Daily Saquinavir Soft-Gelatin Capsule/Ritonavir in Antiretroviral-Naive, HIV-Infected Patients.CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003
P2860
Q24235724-37DD0CCA-CCAB-4BC2-8E40-50AFE2F847ADQ24240224-C4CC4165-AB0F-49A0-B24E-8B35C25BED13Q30240127-8047724F-483E-4299-99AA-71913D449CACQ30881919-BC0E5BBD-9CFC-4639-B42D-A9B9BD6E05D1Q33313949-8EA0CCF6-5B67-493B-BC21-004B529B5D44Q33888845-D9E3597C-F1F4-4509-B004-417171414E37Q34760550-8CCF5FC3-B920-4AE0-91FA-31B622E7BBA7Q34841884-0B33B22A-E327-4209-9B47-C60C8F9DBC44Q35156231-391473A9-4C59-4F8A-BFCC-D81F9B4C5E73Q35609730-FE64E472-7E02-4566-AEF7-37548D57CBC0Q36120838-E8D11B46-83CA-4C4B-8449-3E68DACE0616Q37205433-5FBBEBBC-722B-49AF-86D0-430AC550C30FQ41642008-1F17B907-CE40-468E-9C8B-A4B049F2160DQ41934362-D824D05B-4F60-4F55-8E02-8AA51F32DB43Q42062012-FF8E5F47-5A31-4BF5-A1E9-EC5DE4AD682EQ42776834-4E9C8588-E512-4E6C-9DE5-FA5C0E663338Q44108848-BFC6AECB-77FA-4413-A3EE-CF135885EBD7Q44309066-2796DA6F-0D0B-4E2F-A500-A38A772A5870Q44604254-060EAA37-AE33-4A36-86E5-437A150F74E1Q45723089-5B5443E7-86FC-4F47-A442-9E9199646309Q50119529-2D5F6D67-124C-4042-B18C-87D0F31FE783Q50571503-9D605A2F-6F3B-47CE-8628-F90E9F8FEA49Q55698438-A0489384-C173-4297-BA6C-B1E237BCB950Q57180219-055108A3-15BC-4C40-A2B8-483A76D00535
P2860
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
British HIV Association (BHIVA ...... s with antiretroviral therapy.
@en
type
label
British HIV Association (BHIVA ...... s with antiretroviral therapy.
@en
prefLabel
British HIV Association (BHIVA ...... s with antiretroviral therapy.
@en
P2860
P1433
P1476
British HIV Association (BHIVA ...... s with antiretroviral therapy.
@en
P2093
BHIVA Executive Committee
BHIVA Writing Committee
P2860
P304
P356
10.1046/J.1464-2662.2001.00083.X
P577
2001-10-01T00:00:00Z